Peregrine Pharmaceuticals Inc. (PPHM) Stock Ratings


View Stock Quote:

PPHM

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 6 ratings

View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
mero_2 05/23/2013 1 month $1.59 $1.70 +7.26% 7 Active
Comments: pass resestant $1.52 and get approve from FDA on phrase III
marcelo aniloel zampolli 04/08/2013 3 months $1.39 $1.70 +22.3% 22 Active
Comments:
tambor 04/08/2013 3 months $1.43 $1.70 +18.88% 18 Active
Comments:
Kreuz55 01/17/2013 3 months $2.11 $1.46 -30.81% -30 Ended
Comments:
lambreff 01/12/2013 1 Year $2.10 $1.70 -19.05% -19 Active
Comments:
JOKER66 12/03/2012 1 week $1.50 $1.21 -19.33% -19 Ended
Comments:
Lady Gaviria 10/18/2012 3 months $0.81 $2.17 +168.7% 168 Ended
Comments:
Parlakemre 09/25/2012 1 month $1.16 $0.68 -41.38% -41 Ended
Comments:
TinVestor1 09/24/2012 1 month $1.24 $0.68 -44.92% -44 Ended
Comments: Rebound
PENNYSTOCKDON_1 08/08/2012 3 months $1.90 $0.80 -57.68% -57 Ended
Comments: Industry sector growing or poised for growth
Vincent_20 07/17/2012 1 Year $1.34 $1.70 +26.87% 26 Active
Comments: outstanding Phase II data indicates high likelihood of success for FDA approval
PGG 07/14/2012 3 months $0.97 $0.77 -20.62% -20 Ended
Comments: Upcoming product launch will be successful
Thurly 07/13/2012 1 Year $1.05 $1.70 +61.89% 61 Active
Comments: Outstanding PIIb data in NSCLC, implications for all solid tumors.
john conroy 06/04/2012 3 months $0.54 $2.54 +370.46% 370 Ended
Comments: Upcoming product launch will be successful
VTrader 05/10/2011 1 Year $2.33 $1.28 -45.06% -45 Ended
Comments: This stock is undervalued
Izabelka 01/26/2011 1 Year $2.38 $1.28 -46.22% -46 Ended
Comments: Industry sector growing or poised for growth
Stehauf 01/12/2010 3 months N/A Ended
Comments: Peregrine Pharmaceuticals is ready for 2010 and about that out. Peregrine Pharmaceuticals ist bereit für 2010 und drüber hinaus.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.